191089-59-5 Usage
Uses
Used in Pharmaceutical Industry:
K-7174 is used as an anti-cancer agent for its ability to inhibit the farnesyl protein transferase enzyme, which is involved in the development of certain types of cancer. By blocking the enzyme, K-7174 can suppress tumor growth and progression, as demonstrated in animal models, making it a candidate for further development in cancer treatment.
Used in Cancer Research:
In the field of cancer research, K-7174 is utilized to study the role of FPTase in cancer development and to explore the potential of inhibiting this enzyme as a therapeutic strategy. This research can provide insights into the molecular mechanisms of cancer and contribute to the development of new cancer treatments.
Used in Drug Development:
K-7174 serves as a lead compound in drug development programs aimed at creating new medications for the treatment of cancer. Its selectivity for FPTase and demonstrated efficacy in suppressing tumor growth make it a valuable starting point for the design and optimization of novel therapeutic agents targeting this enzyme.
Check Digit Verification of cas no
The CAS Registry Mumber 191089-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,0,8 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 191089-59:
(8*1)+(7*9)+(6*1)+(5*0)+(4*8)+(3*9)+(2*5)+(1*9)=155
155 % 10 = 5
So 191089-59-5 is a valid CAS Registry Number.
191089-59-5Relevant articles and documents
A straightforward synthesis of K-7174, a GATA-specific inhibitor
Majik, Mahesh S.,Yu, Jin Ha,Jeong, Lak Shin
, p. 2903 - 2906 (2012/10/29)
K-7174, a GATA-specific inhibitor, is a putative anti-inflammatory agent that attenuates effects of inflammatory cytokines in certain cell types. An expeditious four-step synthesis of K-7174 is described in this paper. The route employs Wittig olefination
Inhibitors for cell adhesion and cellular infiltration
-
, (2008/06/13)
The present invention is directed to a cell adhesion inhibitory agent, cellular infiltration inhibitory agent, antiallergic agent, antiasthmatic agent, and antiphlogistic, which contains a compound of the following formula (1): STR1 wherein each of R